Literature DB >> 30152110

Heterogeneity of colon and rectum cancer incidence across 612 SEER counties, 2000-2014.

Pavel Chernyavskiy1,2,3, Victoria M Kennerley1, Ahmedin Jemal4, Mark P Little2, Philip S Rosenberg1.   

Abstract

Recent analyses have suggested decreases over time in colorectal cancer incidence at older ages (≥55 years) but increases at younger ages (20-54 years). Understanding the geographic heterogeneity of incidence facilitates resource allocation for potential interventions and advances our knowledge of differential etiologies for these cancers. We performed age-period-cohort analysis using 2000-2014 county-level incidence from the Surveillance, Epidemiology, and End Results (SEER) database, estimating relative risk (RR) and age-adjusted annual percent change (Net Drifts) simultaneously for 612 counties via a hierarchical model, separately for colon and rectum cancer, stratified by age group (20-54 vs. 55-84). We also studied correlates of RR and Net Drift with various county-level characteristics. In all SEER counties, colon and rectum cancer incidence rates increased at ages 20-54, whereas rates decreased at ages 55-84. There was marked heterogeneity in both RR and Net Drift among states and counties for both cancer types. Maps of county RR and Net Drift revealed localized clusters in several states. For both cancer types, counties with high RR and unfavorable Net Drift tended to have higher prevalence of obesity and diabetes and to be of a lower socioeconomic status. Counties with higher overall screening rates tended to have lower Net Drifts for both cancer types. Increasing colorectal cancer incidence in the younger age group is geographically widespread, although there is significant heterogeneity in temporal trends and risk both within and between states. These geographic patterns correlate with different county-level characteristics depending on cancer type and age group.
© 2018 UICC.

Entities:  

Keywords:  SEER; colorectal cancer; county-level incidence; geographic disparities

Mesh:

Year:  2019        PMID: 30152110     DOI: 10.1002/ijc.31776

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis.

Authors:  Younghoon Kim; Nam Yun Cho; Gyeong Hoon Kang
Journal:  J Pathol Transl Med       Date:  2022-05-15

2.  A systematic review of methods to estimate colorectal cancer incidence using population-based cancer registries.

Authors:  Norah Alsadhan; Alaa Almaiman; Mar Pujades-Rodriguez; Cathy Brennan; Farag Shuweihdi; Sultana A Alhurishi; Robert M West
Journal:  BMC Med Res Methodol       Date:  2022-05-19       Impact factor: 4.612

3.  Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study.

Authors:  Xueliang Ding; Shaobo Tian; Jia Hu; Guobin Wang; Xiangnan Yu; Daan Fu; Ye Yuan; Lin Wang; Zheng Wang
Journal:  Int J Colorectal Dis       Date:  2021-06-01       Impact factor: 2.571

4.  Spatially varying age-period-cohort analysis with application to US mortality, 2002-2016.

Authors:  Pavel Chernyavskiy; Mark P Little; Philip S Rosenberg
Journal:  Biostatistics       Date:  2020-10-01       Impact factor: 5.899

5.  NDC1 is a Prognostic Biomarker and Associated with Immune Infiltrates in Colon Cancer.

Authors:  Meng Liu; Rui Yuan; Shifei Liu; Yonggan Xue; Xuning Wang
Journal:  Int J Gen Med       Date:  2021-11-25

6.  Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.

Authors:  Brittny C Davis Lynn; Pavel Chernyavskiy; Gretchen L Gierach; Philip S Rosenberg
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 11.816

7.  Designing an Effective Colorectal Cancer Screening Program in Egypt: A Qualitative Study of Perceptions of Egyptian Primary Care Physicians and Specialists.

Authors:  Lori Brand Bateman; Somaia Khamess; Salah-Eldin Abdelmoneim; Waleed Arafat; Mona N Fouad; Yomna Khamis; Abbas Omar; Randa Salah Abdelmoneim; Isabel Scarinci
Journal:  Oncologist       Date:  2020-02-24       Impact factor: 5.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.